Cell-killing by paclitaxel in a metastatic murine melanoma cell line is mediated by extensive telomere erosion with...

Area of Science:

• Oncology
• Cell Biology
• Genetics

Background:

• Paclitaxel is a chemotherapy drug.
• Water-soluble paclitaxel conjugates improve drug delivery.
• Melanoma is a type of skin cancer.

Purpose of the Study:

• To compare the effects of paclitaxel and its water-soluble conjugates on chromosome morphology and apoptosis.
• To investigate the impact of these drugs on a metastatic murine melanoma cell line.

Main Methods:

• Murine melanoma cells were treated with paclitaxel and its conjugates at various concentrations and durations.
• Chromosome morphology was analyzed, including telomeric associations and aberrations.
• Apoptosis was assessed by observing apoptotic bodies and chromatin condensation.
• Fluorescence in situ hybridization (FISH) was used to evaluate telomeric signal intensity.

Main Results:

• Paclitaxel and conjugates increased chromosome aberrations, polyploidization, and distorted morphology.
• Reduced telomeric signal intensity and increased telomeric associations were observed.
• Apoptotic bodies and chromatin condensation were prevalent in treated cells.
• No significant change in telomerase activity was detected.

Conclusions:

• Paclitaxel and its water-soluble conjugates induce cell death in melanoma cells.
• Drug-induced apoptosis is linked to telomere loss, evidenced by reduced telomeric signals and increased associations.
• These findings provide in vitro insights into the mechanisms of paclitaxel-induced cytotoxicity.